Literature DB >> 12114688

Immunohistochemical Localization of Chromostatin and Pancreastatin, Chromogranin A-Derived Bioactive Peptides, in Normal and Neoplastic Neuroendocrine Tissues.

Noriko Kimura, Akihiro Funakoshi, Dominique Aunis, Kayoko Tateishi, Wakako Miura, Hiroshi Nagura.   

Abstract

Despite the widespread distribution of chromogranin A (CgA) in neuroendocrine tissues, the biological function of CgA has not yet been elucidated. The primary amino acid sequence of CgA, elucidated by cDNA analysis, has been revealed to include several pairs of basic amino acid residues that are homologous to the bioactive peptides, such as pancreastatin (PST) and chromostatin (CST). Using antibodies for human PST and CST, the immunohistochemical localization of these peptides was investigated in neuroendocrine tissues, including human pituitary glands, pancreas, adrenal medulla, various types of neuroendocrine neoplasms (13 pheochromocytomas, 10 medullary thyroid carcinomas, 11 pancreatic endocrine tumors, and 19 carcinoid tumors), and the cell line QGP-1N derived from human somatostatin-producing pancreatic endocrine tumor. Variable immunoreactive intensities of PST and CST were seen, but both peptides were detectable in all neuroendocrine tissues and in most of the neoplasms. Immunoreactivity for both PST and CST was observed in 100 and 73%, respectively, of pancreatic endocrine tumors, all pheochromocytomas, and 80 and 40%, respectively, of medullary thyroid carcinomas, as well as all nonrectal carcinoid tumors. In rectal carcinoids, cells immunoreactive for PST and CST were sparse. The distribution of PST and CST was similar to that of CgA, and it is considered that these peptides are simultaneously processed from CgA, and may play roles in autocrine and paracrine regulation on various hormones in addition to their previously known functions.

Entities:  

Year:  1995        PMID: 12114688     DOI: 10.1007/bf02914987

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  23 in total

1.  Differential subcellular distribution of PC1, PC2 and furin in bovine adrenal medulla and secretion of PC1 and PC2 from this tissue.

Authors:  R Kirchmair; C Egger; P Gee; R Hogue-Angeletti; R Fischer-Colbrie; A Laslop; H Winkler
Journal:  Neurosci Lett       Date:  1992-08-31       Impact factor: 3.046

2.  Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.

Authors:  K Tatemoto; S Efendić; V Mutt; G Makk; G J Feistner; J D Barchas
Journal:  Nature       Date:  1986 Dec 4-10       Impact factor: 49.962

3.  Specific endocrine tissue marker defined by a monoclonal antibody.

Authors:  R V Lloyd; B S Wilson
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

4.  Ultrastructural localization of chromogranin: a potential marker for the electron microscopical recognition of endocrine cell secretory granules.

Authors:  I M Varndell; R V Lloyd; B S Wilson; J M Polak
Journal:  Histochem J       Date:  1985-09

5.  Plasma pancreastatin-like immunoreactivity in various diseases.

Authors:  K Tateishi; A Funakoshi; H Wakasugi; H Iguchi; H Shinozaki; M Abe; S Funakoshi; H Tamamura; H Yajima; Y Matsuoka
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

6.  Chromogranin A and B messenger ribonucleic acids in pituitary and other normal and neoplastic human endocrine tissues.

Authors:  R V Lloyd; A Iacangelo; L E Eiden; M Cano; L Jin; M Grimes
Journal:  Lab Invest       Date:  1989-04       Impact factor: 5.662

7.  Immunocytochemical localization of androgen receptor with polyclonal antibody in paraffin-embedded human tissues.

Authors:  N Kimura; A Mizokami; T Oonuma; H Sasano; H Nagura
Journal:  J Histochem Cytochem       Date:  1993-05       Impact factor: 2.479

8.  Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum.

Authors:  D T O'Connor
Journal:  Regul Pept       Date:  1983-07

9.  Proprotein and prohormone convertases of the subtilisin family Recent developments and future perspectives.

Authors:  N G Seidah; M Chrétien
Journal:  Trends Endocrinol Metab       Date:  1992 May-Jun       Impact factor: 12.015

10.  Secretion from chromaffin cells is controlled by chromogranin A-derived peptides.

Authors:  J P Simon; M F Bader; D Aunis
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

View more
  4 in total

Review 1.  Neuroendocrine differentiation of prostate cancer: a review.

Authors:  Vamsi Parimi; Rajen Goyal; Kate Poropatich; Ximing J Yang
Journal:  Am J Clin Exp Urol       Date:  2014-12-09

2.  Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned.

Authors:  Mark Bloomston; Osama Al-Saif; Dori Klemanski; Joseph J Pinzone; Edward W Martin; Bryan Palmer; Gregory Guy; Hooman Khabiri; E Christopher Ellison; Manisha H Shah
Journal:  J Gastrointest Surg       Date:  2007-03       Impact factor: 3.267

3.  Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review.

Authors:  Lawrence A Shirley; Megan McNally; Ravi Chokshi; Natalie Jones; Patrick Tassone; Gregory Guy; Hooman Khabiri; Carl Schmidt; Manisha Shah; Mark Bloomston
Journal:  World J Surg Oncol       Date:  2015-05-01       Impact factor: 2.754

4.  The proliferation marker Ki67, but not neuroendocrine expression, is an independent factor in the prediction of prognosis of primary prostate cancer patients.

Authors:  Mariarosa Pascale; Cinzia Aversa; Renzo Barbazza; Barbara Marongiu; Salvatore Siracusano; Flavio Stoffel; Sando Sulfaro; Enrico Roggero; Serena Bonin; Giorgio Stanta
Journal:  Radiol Oncol       Date:  2016-07-19       Impact factor: 2.991

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.